Trials / Sponsors / CuraSen Therapeutics, Inc.
CuraSen Therapeutics, Inc.
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study in Subjects With Neurogenic Orthostatic Hypotension Neurogenic Orthostatic Hypotension | Phase 2 | 2025-09-12 |
| Withdrawn | A Study of CST-103 Co-administered With CST-107 in Subjects With Parkinson's Disease Having Freezing of Gait ( Freezing of Gait Symptoms in Parkinson's Disease | Phase 2 | 2024-06-01 |
| Completed | A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Mild Cognitive Impairment, Dementia | Phase 2 | 2022-04-11 |
| Withdrawn | A Study of CST-2032 in Subjects With Cognitive Impairment Mild Cognitive Impairment (MCI), Parkinson Disease (PD) | Phase 1 | 2021-10-01 |
| Completed | A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Dis Mild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's Disease Dementia | Phase 2 | 2021-06-28 |